×
Back to Agenda
Portfolio Management in Pharma: Strategies and Insights from Large, Medium, and Small Pharma Organizations
Session Chair(s)
Erin Mulrooney, MSC, PMP
Director, Portfolio Analysis & Management, Daiichi Sankyo Co., Ltd., United States
This panel discussion explores the diverse strategies employed by organizations in managing their portfolio across the value chain. Experts will discuss how systems, tools, benchmarks and visualizations are utilized to enhance decision-making.
Learning Objective : Describe the different Portfolio Management approaches used across the pharmaceutical value chain in organizations of varying size; Outline success factors for effective Portfolio Management within your own organization.
Speaker(s)
Christine Mears, MBA, PMP
Founder, Lead Consultant, Premiere Consulting Services LLC, United States
Biotech Perspective
Katie Bloom
Executive Director, Co-Head of PMO, Program Management Office, Ultragenyx, United States
Rare Disease Industry Perspective
Rosa Tarng, MA
Early Development Leader, GSK, United States
Large Pharma Industry Perspective
Have an account?